Journal of the American Chemical Society
Page 4 of 5
1
2
3
4
5
6
7
8
alcohol and the phenyl group on the ligand.15c This interaction is
consistent with the requirements described above.
gew. Chem., Int. Ed. 2009, 48, 154. (c) Urkalan, B. K.; Sigman, M. S.
Angew. Chem., Int. Ed. 2009, 48, 3146. (d) Rene, O.; Lapointe, D.;
́
Fagnou, K. Org. Lett. 2009, 11, 4560. (e) Stokes, B. J.; Liao, L.; de
Andrade, A. M.; Wang, Q.; Sigman, M. S. Org. Lett. 2014, 16, 4666.
(f) You, W.; Brown, M. K. J. Am. Chem. Soc. 2014, 136, 14730. (g)
Tang, C.; Xie, Z. Angew. Chem., Int. Ed. 2015, 54, 7662. (h) You, W.;
Brown, M. K. J. Am. Chem. Soc. 2015, 137, 14578.
Figure 3. Proposed lone pair-π interaction as a controlling ele-
ment in the transition state.
(4) (a) Li, H.; Mazet, C. Org. Lett. 2013, 15, 6170. (b) Larionov, E.;
Lin, L.; Guenee, L.; Mazet, C. J. Am. Chem. Soc. 2014, 136, 16882.
́
́
9
(5) Ziadi, A.; Martin, R. Org. Lett. 2012, 14, 1266.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
(6) (a) Weisenburger, G. A.; Beak, P. J. Am. Chem. Soc., 1996, 118,
12218. (b) Bull, S. D.; Davies, S. G.; Nicholson, R. L.; Sanganee, H.
J.; Smith, A. D. Org. Biomol. Chem. 2003, 1, 2886. (c) Li, T.; Zhu, J.;
Wu, D.; Li, X.; Wang, S.; Li, H.; Li, J.; Wang, W. Chem.–Eur. J.
2013, 19, 9147. (d) Dell'Amico, L.; Companyó, X.; Naicker, T.;
Bräuer, T. M.; Jørgensen, K. A. Eur. J. Org. Chem. 2013, 5262. (e)
Alonso, D. A.; Kitagaki, S.; Utsumi, N.; Barbas, C. F. Angew. Chem.,
Int. Ed. 2008, 47, 4588. (f) Seo, W. S.; Kim, S. Tetrahedron Lett.
2012, 53, 2809. (g) Izquierdo, J.; Orue, A.; Scheidt, A. K. J. Am.
Chem. Soc. 2013, 135, 10634. (h) Lu, P.; Jackson, J. J.; Eickhoff, J. A.;
Zakarian, A. J. Am. Chem. Soc. 2015, 137, 656. (i) Nishimura, T.;
Matsumura, S.; Maeda, Y.; Uemura, S. Chem. Commun. 2002, 50. (j)
Matsumura, S.; Maeda, Y.; Nishimura, T.; Uemura, S. J. Am. Chem.
Soc. 2003, 125, 8862. (k) Zhang, C.; Yun, J. Org. Lett. 2013, 15, 3416.
(7) For selected our group works, see: (a) Werner, E. W.; Mei, T.-
S.; Burckle, A. J.; Sigman, M. S. Science 2012, 338, 1455. (b) Mei,
T.-S.; Werner, E. W.; Burckle, A. J.; Sigman, M. S. J. Am. Chem. Soc.
2013, 135, 6830. (c) Mei, T.-S.; Patel, H. H.; Sigman, M. S. Nature
2014, 508, 340.
(8) For selected other group works, see: (a) Larock, R. C.; Leung,
W.-Y.; Stolz-Dunn, S. Tetrahedron Lett. 1989, 30, 6629. (b) Bouquil-
lon, S.; Ganchegui, B.; Estrine, B.; Hénin, F.; Muzart, J. J. Organomet.
Chem. 2001, 634, 153. (c) Berthiol, F.; Doucet, H.; Santelli, M. Tetra-
hedron 2006, 62, 4372. (d) Correia, C. R. D.; Oliveira, C. C.; Salles Jr,
A. G.; Santos, E. A. F. Tetrahedron Lett. 2012, 53, 3325. (e) Oliveira,
C. C.; R. Angnes, A.; Correia, C. R. D. J. Org. Chem. 2013, 78, 4373.
(f) Angnes, R. A.; Oliveira, J. M.; Oliveira, C. C.; Martins, N. C.;
Correia, C. R. D. Chem.–Eur. J. 2014, 20, 13117. (g) Oliveira, C. C.;
Pfaltz, A.; Correia, C. R. D. Angew. Chem., Int. Ed. 2015, 54, 14036.
(9) (a) Xu, L.-P.; Hilton, M. J.; Zhang, X.; Norrby, P. O.; Wu, Y.-
D.; Sigman, M. S.; Wiest, O. J. Am. Chem. Soc. 2014, 136, 1960. (b)
Hilton, M. J.; Xu, L.-P.; Norrby, P. O.; Wu, Y.-D.; Wiest, O.; Sigman,
M. S. J. Org. Chem. 2014, 79, 11841.
(10) For selected recent works, see: (a) Parrish, J. P.; Jung, Y. C.;
Shin, S.; Jung, K. W. J. Org. Chem., 2002, 6, 7127. (b) Werner, E. W.;
Sigman, M. S. J. Am. Chem. Soc., 2010, 132, 13981. (c) Werner, E.
W.; Sigman, M. S. J. Am. Chem. Soc., 2011, 133, 9692.
(11) No product was observed using 3-pyridinylboronic acid, 3-
furanylboronic acid and 3-thienylboronic acid.
(12) For details on the assignment of absolute configuration, please
see the supporting information.
(13) Sigman, M. S.; Harper, K. C.; Bess, E. N.; Milo, A. Acc. Chem.
Res., 2016, 49, 1292.
(14) (a) Guckian, K. M.; B. A.; Ren, R. X.; Sheils, C. J.; Tah-
massebi, D. C.; Kool, E. T. J. J. Am. Chem. Soc. 2000, 122, 2213. (b)
Watt, M.; Hardebeck, L. K. E.; Kirkpatrick, C. C.; Lewis, M. J. Am.
Chem. Soc. 2011, 133, 3854.
(15) (a) Raju, R. K.; Bloom, J. W. G.; An, Y.; Wheeler, S. E. Chem-
PhysChem 2011, 12, 3116. (b) Sherrill, C. D. Acc. Chem. Res. 2013,
46, 1020. (c) Singh, S. K.; Das, A. Phys. Chem. Chem. Phys. 2015,
17, 9596.
In summary, we have successfully developed a method to
synthesize enantiomerically enriched 1,2-diaryl carbonyl
compounds,
a common pharmacophore, in good to high
enantioselectivity. The insight gained through uni- and
multivariate correlations has revealed key properties in both the
substrate and ligand, leading to a proposed attractive interaction
responsible for achieving a highly selective process. Detailed
mechanistic studies are in progress to investigate the unexpected
effect of chain length on enantioselectivity and the potential role
of noncovalent π interactions as controlling elements in the enan-
tiodetermining step.
ACKNOWLEDGMENTS. The synthetic aspects were support-
ed by NIH (R01GM063540) and the modeling was supported by
NSF (CHE-1361296). We gratefully acknowledge the Center for
High Performance Computing (CHPC) at the University of Utah.
Z.-M.C. would like to thank Shanghai Jiao Tong University for a
postdoctoral fellowship.
Supporting Information Available: Experimental details, ana-
lytical data for products, NMR spectra of products, computations
and modeling details can be found in the supporting information.
The Supporting Information is available free of charge via the
REFERENCES
(1) (a) Manley, P. J.; Miller, W. H.; Uzinskas, I. N. (SmithKline
Beecham Corporation) Patent EP1218005 A2, July 3, 2002. (b) Mil-
lera, W. H.; Manley, P. J.; Cousins, R. D.; Erhard, K. F.; Heerding, D.
A.; Kwon, C.; Ross, S. T.; Samanen, J. M.; Takata, D. T.; Uzinskas, I.
N.; Yuan, C. C. K.; Haltiwanger, R. C.; Gress, C. J.; Lark, M. W.;
Hwang, S.-M.; James, I. E.; Rieman, D. J.; Willette, R. N.; Yue, T.-L.;
Azzarano, L. M.; Salyers, K. L.; Smith, B. R.; Ward, K. W.; Johanson,
K. O.; Huffman, W. F. Bioorg. Med. Chem. Lett. 2003, 13, 1483. (c)
Wang, F.; Li, J.; Sinn, A. L.; Knabe, W. E.; Khanna, M.; Jo, I.; Silver,
J. M.; Oh, K.; Li, L.; Sandusky, G. E.; Sledge, G. W.; Nakshatri, H.;
Jones, D. R.; Pollok, K. E.; Meroueh, S. O. J. Med. Chem. 2011, 54,
7193. (d) Hasui, T.; Matsunaga, N.; Ora, T.; Ohyabu, N.; Nishigaki,
N.; Imura, Y.; Igata, Y.; Matsui, H.; Motoyaji, T.; Tanaka, T.; Habuka,
N.; Sogabe, S.; Ono, M.; Siedem, C. S.; Tang, T. P.; Gauthier, C. G.;
De Meese, L. A.; Boyd, S. A.; Fukumoto, S. J. Med.
Chem. 2011, 54, 8616. (e) Kim, M.; Ryu, J.; Hah, J. Bioorg. Med.
Chem. Lett. 2013, 23, 1639. (f) Irannejad, H.; Unsal Tan, O.; Ozadali,
K.; Dadashpour, S.; Tuylu Kucukkilinc, T.; Ahangar, N.; Ahmadnejad,
M.; Emami, S. Chem. Biol. Drug Des. 2015, 85, 494. (g) Sun, J.; Chen,
L.; Liu, C.; Wang, Z.; Zuo, D.; Pan, J.; Qi, H.; Bao, K.; Wu, Y.;
Zhang, W. Chem. Biol. Drug Des. 2015, 86, 1541. (h) Koo, K. A.;
Lorent, K.; Gong, W.; Windsor, P.; Whittaker, S. J.; Pack, M.; Wells,
R. G.; Porter, J. R. Chem. Res. Toxicol. 2015, 28, 1519.
(2) (a) Lenz, G. R. J. Org. Chem. 1988, 53, 5791. (b) Mandal, S. K.;
Jana, S.; Roy, S. C. Tetrahedron Lett. 2005, 46, 6115. (c) Franzoni, I.;
L.; Guenee, L.; Mazet, C. Org. Biomol. Chem. 2015, 13, 6338.
(16) Biedermann, F.; Schneider, H.-J. Chem. Rev. 2016, 116, 5216.
́
́
(3) (a) Trejos, A.; Fardost, A.; Yahiaoui, S.; Larhed, M. Chem.
Commun. 2009, 7587. (b) Lundin, M. P.; Esquivias, J.; Fu, C. G. An-
4
ACS Paragon Plus Environment